ACA
Avoro Capital Advisors’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,600,000
| Closed | -$60.9M | – | 32 |
|
|
2019
Q3 | $60.9M | Buy |
1,600,000
+1,200,000
| +300% | +$45.7M | 2.54% | 15 |
|
|
2019
Q2 | $17.4M | Hold |
400,000
| – | – | 0.6% | 26 |
|
|
2019
Q1 | $15.2M | Hold |
400,000
| – | – | 0.66% | 24 |
|
|
2018
Q4 | $17.2M | Sell |
400,000
-13,196
| -3% | -$568K | 1.03% | 20 |
|
|
2018
Q3 | $20.3M | Sell |
413,196
-1,047,414
| -72% | -$51.5M | 0.93% | 22 |
|
|
2018
Q2 | $46.8M | Sell |
1,460,610
-254,462
| -15% | -$8.16M | 1.8% | 20 |
|
|
2018
Q1 | $53.4M | Buy |
1,715,072
+866,500
| +102% | +$27M | 2.55% | 16 |
|
|
2017
Q4 | $38.7M | Sell |
848,572
-462,888
| -35% | -$21.1M | 2.51% | 16 |
|
|
2017
Q3 | $49.2M | Buy |
1,311,460
+845,642
| +182% | +$31.8M | 3.82% | 9 |
|
|
2017
Q2 | $22.2M | Buy |
465,818
+55,818
| +14% | +$2.66M | 2.81% | 13 |
|
|
2017
Q1 | $18.7M | Buy |
+410,000
| New | +$18.7M | 2.39% | 16 |
|